Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Disposition to Issuer of 200,000 CHRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Coherus Oncology, Inc. (CHRS) | Disposition to Issuer | 200,000 | n/a |
| Jan 26, 2026 | Coherus Oncology, Inc. (CHRS) | Grant/Award | 375,000 | n/a |
| Jan 23, 2026 | Coherus Oncology, Inc. (CHRS) | Tax Withholding | 11,839 | $18.4K |
| May 9, 2025 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 375,000 | n/a |
| Jan 23, 2025 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 11,810 | $16.4K |
| Jan 14, 2025 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 575,000 | n/a |
| Jan 8, 2025 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 11,810 | $19.6K |
| Jul 25, 2024 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 196,500 | n/a |
| Jan 24, 2024 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 11,218 | $27.4K |
| Jan 9, 2024 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 11,781 | $34.4K |